187 related articles for article (PubMed ID: 31570706)
1. Ubiquitin ligase TRIM71 suppresses ovarian tumorigenesis by degrading mutant p53.
Chen Y; Hao Q; Wang J; Li J; Huang C; Zhang Y; Wu X; Lu H; Zhou X
Cell Death Dis; 2019 Sep; 10(10):737. PubMed ID: 31570706
[TBL] [Abstract][Full Text] [Related]
2. TRIM71 suppresses tumorigenesis via modulation of Lin28B-let-7-HMGA2 signaling.
Yin J; Kim TH; Park N; Shin D; Choi HI; Cho S; Park JB; Kim JH
Oncotarget; 2016 Nov; 7(48):79854-79868. PubMed ID: 27821801
[TBL] [Abstract][Full Text] [Related]
3. Poly r(C) Binding Protein 1 Regulates Posttranscriptional Expression of the Ubiquitin Ligase TRIM56 in Ovarian Cancer.
Zhao L; Wang ZG; Zhang P; Yu XF; Su XJ
IUBMB Life; 2019 Feb; 71(2):177-182. PubMed ID: 30281912
[TBL] [Abstract][Full Text] [Related]
4. Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1.
Tanaka N; Zhao M; Tang L; Patel AA; Xi Q; Van HT; Takahashi H; Osman AA; Zhang J; Wang J; Myers JN; Zhou G
Oncogene; 2018 Mar; 37(10):1279-1292. PubMed ID: 29269868
[TBL] [Abstract][Full Text] [Related]
5. The ubiquitin ligase TRIM21 regulates mutant p53 accumulation and gain of function in cancer.
Liu J; Zhang C; Xu D; Zhang T; Chang CY; Wang J; Liu J; Zhang L; Haffty BG; Zong WX; Hu W; Feng Z
J Clin Invest; 2023 Mar; 133(6):. PubMed ID: 36749630
[TBL] [Abstract][Full Text] [Related]
6. The ubiquitin ligase TRIM56 inhibits ovarian cancer progression by targeting vimentin.
Zhao L; Zhang P; Su XJ; Zhang B
J Cell Physiol; 2018 Mar; 233(3):2420-2425. PubMed ID: 28771721
[TBL] [Abstract][Full Text] [Related]
7. The ubiquitin ligase human TRIM71 regulates let-7 microRNA biogenesis via modulation of Lin28B protein.
Lee SH; Cho S; Kim MS; Choi K; Cho JY; Gwak HS; Kim YJ; Yoo H; Lee SH; Park JB; Kim JH
Biochim Biophys Acta; 2014 May; 1839(5):374-86. PubMed ID: 24602972
[TBL] [Abstract][Full Text] [Related]
8. SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker.
Kolukula VK; Sahu G; Wellstein A; Rodriguez OC; Preet A; Iacobazzi V; D'Orazi G; Albanese C; Palmieri F; Avantaggiati ML
Oncotarget; 2014 Mar; 5(5):1212-25. PubMed ID: 24681808
[TBL] [Abstract][Full Text] [Related]
9. The Janus Face of p53-Targeting Ubiquitin Ligases.
Hao Q; Chen Y; Zhou X
Cells; 2020 Jul; 9(7):. PubMed ID: 32660118
[TBL] [Abstract][Full Text] [Related]
10. TRIM71 binds to IMP1 and is capable of positive and negative regulation of target RNAs.
Foster DJ; Chang HM; Haswell JR; Gregory RI; Slack FJ
Cell Cycle; 2020 Sep; 19(18):2314-2326. PubMed ID: 32816599
[TBL] [Abstract][Full Text] [Related]
11. TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer.
Takayama KI; Suzuki T; Tanaka T; Fujimura T; Takahashi S; Urano T; Ikeda K; Inoue S
Oncogene; 2018 Apr; 37(16):2165-2180. PubMed ID: 29379164
[TBL] [Abstract][Full Text] [Related]
12. The mRNA repressor TRIM71 cooperates with Nonsense-Mediated Decay factors to destabilize the mRNA of CDKN1A/p21.
Torres-Fernández LA; Jux B; Bille M; Port Y; Schneider K; Geyer M; Mayer G; Kolanus W
Nucleic Acids Res; 2019 Dec; 47(22):11861-11879. PubMed ID: 31732746
[TBL] [Abstract][Full Text] [Related]
13. BCL7C suppresses ovarian cancer growth by inactivating mutant p53.
Huang C; Hao Q; Shi G; Zhou X; Zhang Y
J Mol Cell Biol; 2021 May; 13(2):141-150. PubMed ID: 33306126
[TBL] [Abstract][Full Text] [Related]
14. The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1.
Welte T; Tuck AC; Papasaikas P; Carl SH; Flemr M; Knuckles P; Rankova A; Bühler M; Großhans H
Genes Dev; 2019 Sep; 33(17-18):1221-1235. PubMed ID: 31371437
[TBL] [Abstract][Full Text] [Related]
15. SMYD3 promotes epithelial ovarian cancer metastasis by downregulating p53 protein stability and promoting p53 ubiquitination.
Zhang L; Jin Y; Yang H; Li Y; Wang C; Shi Y; Wang Y
Carcinogenesis; 2019 Dec; 40(12):1492-1503. PubMed ID: 31002112
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin ligase DTX3 empowers mutant p53 to promote ovarian cancer development.
Wang S; Hao Q; Li J; Chen Y; Lu H; Wu X; Zhou X
Genes Dis; 2022 May; 9(3):705-716. PubMed ID: 35782979
[TBL] [Abstract][Full Text] [Related]
17. Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation.
Kong LR; Ong RW; Tan TZ; Mohamed Salleh NAB; Thangavelu M; Chan JV; Koh LYJ; Periyasamy G; Lau JA; Le TBU; Wang L; Lee M; Kannan S; Verma CS; Lim CM; Chng WJ; Lane DP; Venkitaraman A; Hung HT; Cheok CF; Goh BC
Nat Commun; 2020 Apr; 11(1):2086. PubMed ID: 32350249
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism governing RNA-binding property of mammalian TRIM71 protein.
Shi F; Zhang K; Cheng Q; Che S; Zhi S; Yu Z; Liu F; Duan F; Wang Y; Yang N
Sci Bull (Beijing); 2024 Jan; 69(1):72-81. PubMed ID: 38036331
[TBL] [Abstract][Full Text] [Related]
19. Differential Gain-of-Function Activity of Three p53 Hotspot Mutants In Vivo.
Xiong S; Chachad D; Zhang Y; Gencel-Augusto J; Sirito M; Pant V; Yang P; Sun C; Chau G; Qi Y; Su X; Whitley EM; El-Naggar AK; Lozano G
Cancer Res; 2022 May; 82(10):1926-1936. PubMed ID: 35320355
[TBL] [Abstract][Full Text] [Related]
20. FBXW7 is involved in the acquisition of the malignant phenotype in epithelial ovarian tumors.
Kitade S; Onoyama I; Kobayashi H; Yagi H; Yoshida S; Kato M; Tsunematsu R; Asanoma K; Sonoda K; Wake N; Hata K; Nakayama KI; Kato K
Cancer Sci; 2016 Oct; 107(10):1399-1405. PubMed ID: 27486687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
